Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 10:49 PM
Study NCT ID:
NCT05337267
Status:
COMPLETED
Last Update Posted:
2023-08-21
First Post:
2022-03-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I Study of Sintilimab in Healthy Chinese Male Subjects
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-13
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-24
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-22
First Submit QC Date:
None
Study First Post Date:
2022-04-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-16
Last Update Post Date:
2023-08-21
Last Update Post Date Type:
ACTUAL